NRC-IRAP Awards $299K towards Development of COVID-19 Tests
With help from NRC-IRAP COVID-19 funding of $299,190, portable coronavirus tests are currently being developed by Canadian biotechnology company Nicoya.
With help from NRC-IRAP COVID-19 funding of $299,190, portable coronavirus tests are currently being developed by Canadian biotechnology company Nicoya.